Published July 12, 2017 | Version v1
Poster Open

In vitro and in vivo study on the effects of inhibitors of angiogenesis in atherosclerosis

Description

In order to test the anti-angiogenic capacity of new compounds we first synthetized a positive control for our future testing, a proven bFGF inhibitor. After that we optimized both the aortic ring assay as a physiological in vitro angiogenesis assay and train the in vivo model of vein graft surgery.

 

Files

Poster Laura Parma Papendal vertical.pdf

Files (332.6 kB)

Name Size Download all
md5:ca664677ebe8df473aa6e6ab317b559e
332.6 kB Preview Download

Additional details

Funding

European Commission
MOGLYNET - Modulation of glycolytic flux as a new approach for treatment of atherosclerosis and plaque stabilization: a multidisciplinary study 675527